Kairos Pharma (NYSEAMERICAN:KAPA – Get Free Report) posted its earnings results on Friday. The company reported ($0.59) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.63) by $0.04, FiscalAI reports.
Kairos Pharma Trading Down 5.6%
NYSEAMERICAN KAPA traded down $0.03 on Friday, hitting $0.45. The company’s stock had a trading volume of 12,561 shares, compared to its average volume of 91,918. Kairos Pharma has a 52-week low of $0.42 and a 52-week high of $7.28. The company’s 50-day simple moving average is $1.08 and its 200 day simple moving average is $2.80. The firm has a market cap of $1.54 million, a P/E ratio of -0.23 and a beta of 1.85.
About Kairos Pharma
Read More
- Five stocks we like better than Kairos Pharma
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Kairos Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kairos Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
